Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis An Analysis of 431 Cases

被引:127
作者
van Werkum, Jochem W. [1 ,4 ]
Heestermans, Antonius A. C. M. [2 ]
de Korte, Fleur I. [1 ]
Kelder, Johannes C. [1 ]
Suttorp, Maarten-Jan [1 ]
Rensing, Benno J. W. M. [1 ]
Zwart, Bastiaan [1 ]
Brueren, B. R. Guus [3 ]
Koolen, Jacques J. [3 ]
Dambrink, Jan-Henk E. [2 ]
van't Hof, Arnoud W. J. [2 ]
Verheugt, Freek W. A. [4 ]
ten Berg, Jurrien M. [1 ]
机构
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands
关键词
stents; thrombosis; risk factors; DRUG-ELUTING STENTS; IMPLANTATION; PREDICTORS; TRIALS;
D O I
10.1161/CIRCULATIONAHA.108.799403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-There are limited data on the long-term clinical outcome after an angiographically confirmed (definite) stent thrombosis (ST). Methods and Results-Four hundred thirty-one consecutive patients with a definite ST were enrolled in this multicenter registry. The primary end point was the composite of cardiac death and definite recurrent ST. Secondary end points were all-cause death, cardiac death, definite recurrent ST, definite and probable recurrent ST, any myocardial infarction, and any target-vessel revascularization. The primary end point occurred in 111 patients after a median follow-up of 27.1 months. The estimated cumulative event rates at 30 days and 1, 2, and 3 years were 18.0%, 23.6%, 25.2%, and 27.9%, respectively. The cumulative incidence rates of definite recurrent ST, definite or probable recurrent ST, any myocardial infarction, and any target-vessel revascularization were 18.8%, 20.1%, 21.3%, and 32.0%, respectively, at the longest available follow-up. Independent predictors for the primary end point were diabetes mellitus, total stent length, severe calcification, American College of Cardiology/American Heart Association B2-C lesions, TIMI (Thrombolysis In Myocardial Infarction) flow grade <3 after percutaneous coronary intervention, and left ventricular ejection fraction <45%. The implantation of an additional coronary stent during the first ST was also associated with unfavorable outcome. Clinical outcome was not affected by the type of previously implanted stent (drug-eluting or bare-metal stent) or the category of ST (early versus late). Conclusions-The long-term clinical outcome after a first definite ST is unfavorable, with a high mortality and recurrence rate. Diabetes mellitus, left ventricular ejection fraction <45%, long total stent length, complex coronary lesions, TIMI flow grade <3 after percutaneous coronary intervention, and implantation of an additional coronary stent during the emergent percutaneous coronary intervention for the ST were associated with this unfavorable outcome. (Circulation. 2009;119:828-834.)
引用
收藏
页码:828 / 834
页数:7
相关论文
共 12 条
  • [1] Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
    Airoldi, Flavio
    Colombo, Antonio
    Morici, Nuccia
    Latib, Azeem
    Cosgrave, John
    Buellesfeld, Lutz
    Bonizzoni, Erminio
    Carlino, Mauro
    Gerckens, Ulrich
    Godino, Cosmo
    Melzi, Gloria
    Michev, Iassen
    Montorfano, Matteo
    Sangiorgi, Giuseppe Massimo
    Qasim, Asif
    Chieffo, Alaide
    Briguori, Carlo
    Grube, Eberhard
    [J]. CIRCULATION, 2007, 116 (07) : 745 - 754
  • [2] The volume of primary angioplasty procedures and survival after acute myocardial infarction
    Canto, JG
    Every, NR
    Magid, DJ
    Rogers, WJ
    Malmgren, JA
    Frederick, PD
    French, WJ
    Tiefenbrunn, AJ
    Misra, VK
    Kiefe, CI
    Barron, HV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) : 1573 - 1580
  • [3] Cutlip DE, 2001, CIRCULATION, V103, P1967
  • [4] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [5] Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)
    de la Torre-Hernandez, Jos M.
    Alfonso, Fernando
    Hernandez, Felipe
    Elizaga, Jaime
    Sanmartin, Marcelo
    Pinar, Eduardo
    Lozano, Inigo
    Vazquez, Jose M.
    Botas, Javier
    Perez de Prado, Armando
    Hernandez, Jose M.
    Sanchis, Juan
    Ruiz Nodar, Juan M.
    Gomez-Jaume, Alfredo
    Larman, Mariano
    Diarte, Jose A.
    Rodriguez-Collado, Javier
    Rumoroso, Jose R.
    Lopez-Minguez, Jose R.
    Mauri, Josepa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : 986 - 990
  • [6] Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    Iakovou, I
    Schmidt, T
    Bonizzoni, E
    Ge, L
    Sangiorgi, GM
    Stankovic, G
    Airoldi, F
    Chieffo, A
    Montorfano, M
    Carlino, M
    Michev, I
    Corvaja, N
    Briguori, C
    Gerckens, U
    Grube, E
    Colombo, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17): : 2126 - 2130
  • [7] Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
    Kuchulakanti, PK
    Chu, WW
    Torguson, R
    Ohlmann, P
    Rha, SW
    Clavijo, LC
    Kim, SW
    Bui, A
    Gevorkian, N
    Xue, ZY
    Smith, K
    Fournadjieva, J
    Suddath, WO
    Satler, LF
    Pichard, AD
    Kent, KM
    Waksman, R
    [J]. CIRCULATION, 2006, 113 (08) : 1108 - 1113
  • [8] Stent thrombosis in randomized clinical trials of drug-eluting stents
    Mauri, Laura
    Hsieh, Wen-hua
    Massaro, Joseph M.
    Ho, Kalon K. L.
    D'Agostino, Ralph
    Cutlip, Donald E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) : 1020 - 1029
  • [9] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
    Morice, M
    Serruys, PW
    Sousa, JE
    Fajadet, J
    Hayashi, EB
    Perin, M
    Colombo, A
    Schuler, G
    Barragan, P
    Guagliumi, G
    Molnar, F
    Falotico, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) : 1773 - 1780
  • [10] Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up
    Park, Duk-Woo
    Park, Seong-Wook
    Park, Kyoung-Ha
    Lee, Bong-Ki
    Kim, Young-Hak
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seung-Jung
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03) : 352 - 356